Teradyne price target raised to $130 from $125 at Susquehanna

Susquehanna raised the firm’s price target on Teradyne to $130 from $125 and keeps a Positive rating on the shares. The firm updated its estimates following its Q1 report. They are pleased with its beat and raise driven by stronger than expected demand from HBM DRAM and Compute.